Medicamen Organics IPO Peer Comparison
Medicamen Organics Limited peer comparison with similar listed entities. (As on March 31, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Medicamen Organics Limited | 3.18 | 3.18 | 17.66 | | 15.83 | 1.93 | |
| Brooks Laboratories Ltd. | -12.57 | -12.57 | 30.10 | 10.60 | -28.26 | 4.43 | |
| Cian Healthcare Ltd | 0.43 | 0.43 | 22.40 | 53.84 | 1.75 | 1.03 | |
| Zenotech Laboratories Ltd. | 1.90 | 1.90 | 14.20 | 38.76 | 14.08 | 5.19 | |
Notes:
- The EPS, NAV, RoNW, and Total Income of our company are taken as per the Restated Financial Statement for the Financial year ended March 31, 2024.
- NAV per share is computed as the closing net worth divided by the weighted average number of paid-up equity shares as on March 31, 2024.
- RoNW has been computed as net profit after tax divided by closing net worth.
- Net worth has been computed in the manner as specified in Regulation 2(1) (hh) of SEBI (ICDR) Regulations, 2018.
